Inicio › Cáncer de seno › Alabama › Birmingham
Ensayos clínicos de Cáncer de seno en Birmingham, AL
24 estudios para Cáncer de seno buscan participantes en centros de Birmingham y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutandoFase 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ReclutandoFase 3
- Central Alabama Research, Birmingham
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
ReclutandoFase 2
- Alabama Oncology, Birmingham
PRE-ISPY Phase I/II Oncology Platform Program
ReclutandoFase 1/2
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
ReclutandoFase 2
- University of Alabama at Birmingham, Birmingham
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
ReclutandoFase 1
- University of Alabama At Birmingham Hospital, Birmingham
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
Reclutando
- The Kirklin Clinic, Birmingham
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
ReclutandoFase 1/2
- University of Alabama at Birmingham, Birmingham
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
ReclutandoFase 2
- University of Alabama at Birmingham, Birmingham
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
ReclutandoSe aceptan voluntarios sanos
- University of Alabama at Birmingham, Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- University of Alabama Birmingham, Birmingham
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
ReclutandoEstudio observacional
- Birmingham Hematology Associates, Birmingham
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
ReclutandoFase 2
- University of Alabama, Birmingham
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
ReclutandoSe aceptan voluntarios sanos
- University of Alabama, Birmingham, Birmingham
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
ReclutandoFase 1
- Uni of Alabama at Birmingham, Birmingham
Promoting Resilience in Women With Breast Cancer (PRISM -MBC)
Reclutando
- The University of Alabama, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ReclutandoFase 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Reclutando
- University of Alabama at Birmingham, Birmingham
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
ReclutandoFase 2
- University of Alabama at Birmingham, Birmingham
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
ReclutandoFase 1 temprana
- The Kirklin Clinic, Birmingham
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
ReclutandoFase 2
- University of Alabama Birmingham, Birmingham
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
Reclutando
- The University of Alabama at Birmingham, Birmingham
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
Reclutando
- University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center (HSROC), Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Birmingham
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Birmingham
- Cáncer (todos los tipos)31 estudios
- Cáncer de ovario23 estudios
- Obesidad23 estudios
- Cáncer de pulmón de células no pequeñas22 estudios
- Leucemia mielógena aguda21 estudios
- Mieloma múltiple18 estudios
- Enfermedad de obstrucción pulmonar crónica17 estudios
- Enfermedad cardiovascular17 estudios
- Diabetes tipo 216 estudios
- Cáncer de endometrio16 estudios
- Sobrepeso16 estudios
- Fibrosis quística16 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.